Overview

Clinical Trial of Safety and Clinical Efficacy of Ergoferon in Liquid Dosage Form in Treatment of Acute Upper Respiratory Tract Infections in Children

Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is: - to assess safety of the liquid dosage form of Ergoferon for treatment of acute upper respiratory tract infections in children; - to assess clinical efficacy of the liquid dosage form of Ergoferon for treatment acute upper respiratory tract infections in children.
Phase:
Phase 3
Details
Lead Sponsor:
Materia Medica Holding